AbbVie to pay Shire $1.64B fee over nixed merger

Published



NORTH CHICAGO, Ill. (AP) — AbbVie is walking away from its proposed $55 billion takeover bid of Shire and has agreed to pay the rival drugmaker a $1.64 billion breakup fee.

The two companies said Monday that they deal was off following the decision last week by AbbVie’s board to withdraw support from the proposed acquisition.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.